Right ventricular outflow tract endocardial unipolar substrate mapping: implications in risk stratification of Brugada syndrome.


Journal

Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007

Informations de publication

Date de publication:
25 Jan 2022
Historique:
received: 12 10 2021
revised: 29 12 2021
accepted: 08 01 2022
entrez: 1 3 2022
pubmed: 2 3 2022
medline: 24 3 2022
Statut: ppublish

Résumé

Brugada syndrome (BrS) is a complex arrhythmogenic disease displaying electrical and micro-structural abnormalities mainly located at the epicardium of the right ventricular outflow tract (RVOT). It is well-known that fibrosis, fatty infiltration, inflammation and reduced gap junction expression have been demonstrated at the epicardial anterior aspect of the RVOT providing the arrhythmogenic substrate for ventricular arrhythmic events in BrS. A number of models have been proposed for the risk stratification of patients with BrS. Endocardial unipolar electroanatomical mapping is an emerging tool that has been reintroduced to identify and quantify epicardial electrical abnormalities. Interestingly, current findings correlate the presence of large-sized endocardial unipolar electroanatomical abnormalities with either ventricular fibrillation inducibility during programmed ventricular stimulation or symptom status. This review aims to present existing data about the role of endocardial unipolar electroanatomical mapping for the identification of RVOT epicardial abnormalities as well as its potential clinical implications in risk stratification of BrS.

Identifiants

pubmed: 35229535
pii: S1530-6550(22)00331-3
doi: 10.31083/j.rcm2302044
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

44

Informations de copyright

© 2022 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. Konstantinos P. Letsas is serving as one of the Guest editors of this journal. We declare that Konstantinos P. Letsas had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Peter A. McCullough.

Auteurs

Konstantinos P Letsas (KP)

Arrhythmia Unit, Onassis Cardiac Surgery Center, 17674 Athens, Greece.

Konstantinos Vlachos (K)

Arrhythmia Unit, Onassis Cardiac Surgery Center, 17674 Athens, Greece.

Michael Efremidis (M)

Arrhythmia Unit, Onassis Cardiac Surgery Center, 17674 Athens, Greece.

Stylianos Dragasis (S)

Arrhythmia Unit, Onassis Cardiac Surgery Center, 17674 Athens, Greece.

Panagiotis Korantzopoulos (P)

Department of Cardiology, University of Ioannina Medical School, 45110 Ioannina, Greece.

Gary Tse (G)

Kent and Medway Medical School, CT2 7FS Canterbury, UK.
Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, 300211 Tianjin, China.

Tong Liu (T)

Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, 300211 Tianjin, China.

George Bazoukis (G)

Department of Cardiology, Medical School, University of Nicosia, 2408 Nicosia, Cyprus.
Department of Cardiology, Larnaca General Hospital, 7036 Larnaca, Cyprus.

Panagioula Niarchou (P)

Second Department of Cardiology, Evangelismos General Hospital of Athens, 10676 Athens, Greece.

Efstathia Prappa (E)

Second Department of Cardiology, Evangelismos General Hospital of Athens, 10676 Athens, Greece.

Frederic Sacher (F)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), 33600 Bordeaux, France.

Meleze Hocini (M)

Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), 33600 Bordeaux, France.

Adrian Baranchuk (A)

Division of Cardiology, Queen's University, Kingston General Hospital, Kingston, K7K Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH